摘要： 2013 年以来，中国学者在国外相关专业杂志上发表了多篇高质量的脑卒中二级预防研究成果，内容涉及中国缺血性卒中患者基于指南的二级预防综合管理项目的实施、氯吡格雷联合阿司匹林在非心源性卒中和短暂性脑缺血发作患者中的预防效果、颅内支架植入术后再狭窄患者的缺血事件复发风险、高血压致脑卒中复发与脑卒中亚型的相关性，以及心房颤动抗凝治疗质量控制对脑卒中复发的影响。本文对上述研究进行简要综述。

关键词: 卒中, 中国, 综述

Abstract: Chinese researchers have published some studies in English journals since 2013 on the secondary prevention of stroke. These studies focused on implementation of a structured guideline-based program for the secondary prevention of ischemic stroke in China, clopidogrel with aspirin in acute minor stroke or transient ischemic attack (TIA), higher risk of recurrent ischemic events in patients with intracranial in-stent restenosis, association of hypertension with stroke recurrence depends on ischemic stroke subtype, impact of quality of anticoagulation control, and so on. In this review, we outline the data of these high-qualitied studies on secondary prevention of stroke.

Key words: Stroke, China, Review